Le Lézard
Classified in: Health
Subject: MAT

TerrAscend to Participate in the 7th Annual Canaccord Genuity Global Cannabis Conference on May 18th in NYC


TORONTO, May 17, 2023 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that its executive management team will participate in the Canaccord Genuity 7th Annual Global Cannabis Conference being held on May 18, 2023 in New York City.

Jason Wild, Chairman of the Board, will participate in a fireside chat with Matt Bottomley, Managing Director, Equity Research at Canaccord Genuity, on Thursday, May 18, 2023, at 2:00 PM ET. Management, including Ziad Ghanem, Chief Executive Officer and Keith Stauffer, Chief Financial Officer, will host one-on-one meetings throughout the conference.

For more information, please click here.

About TerrAscend

TerrAscend is a leading North American cannabis operator with vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan and California and retail operations in Canada. TerrAscend operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Legend, State Flower, and Valhalla Confections. For more information visit www.terrascend.com.

SOURCE TerrAscend


These press releases may also interest you

at 15:20
Chronic virus found in long COVID gut up to 2 years post-infection
Team famous for HIV breakthroughs demonstrates both persistent COVID virus and widespread immune activation in long COVID; provides clear targets for treatment Key points: SARS-CoV-2 double-stranded RNA indicative of viral replication was found in...

at 15:05
CloudMD Receives Court Approval of Proposed Transaction with CPS Capital
CloudMD Software & Services Inc. (the "Company" or "CloudMD"), an innovative health services company transforming the delivery of care, is pleased to announce that it has received a final order from the Supreme Court of British Columbia approving...

at 14:57
TEAMSTERS AT WATSONVILLE COMMUNITY HOSPITAL UNANIMOUSLY RATIFY CONTRACT
Workers at Watsonville Community Hospital represented by Teamsters Local 853 have voted unanimously to ratify a collective bargaining agreement. The new three-year contract includes significant wage increases, a strong benefits package with Teamsters...

at 14:55
Anti-Inflammatory Therapeutics Market size is set to grow by USD 38.7 billion from 2024-2028, Increase in off-label use to boost the market growth, Technavio
The global anti-inflammatory therapeutics market size is estimated to grow by USD 38.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.3% during the forecast period. Increase in off-label use is...

at 14:45
Pulse Biosciences, Inc. Announces the Closing of its Rights Offering
Pulse Biosciences, Inc. (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, announced today the closing of its rights offering and the final results...

at 14:38
Aker ASA: Streamlining Aker BioMarine, crystallizing value and re-investing in Feed Ingredients business
Reference is made to the stock exchange notice by Aker BioMarine ASA ("AKBM") today regarding the sale of its ownership position in the Feed Ingredients business to a new company to be established ("Aker BioMarine Antarctic Holding II AS") owned 60%...

More news about Health...


News published on and distributed by: